Journal
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY
Volume 14, Issue 2, Pages -Publisher
WILEY
DOI: 10.1002/wnan.1749
Keywords
hepatocellular carcinoma; imaging; microspheres; nanoparticles; therapy; transarterial chemoembolization
Funding
- USC Research Center for Liver Diseases Pilot Funding (NIH) [P30 DK048522]
- Department of Radiology, Keck School of Medicine, University of Southern California
Ask authors/readers for more resources
Transarterial chemoembolization (TACE) is a recommended treatment for patients with intermediate and advanced hepatocellular carcinoma (HCC), with drug-eluting bead TACE showing advantages over conventional TACE in terms of survival, treatment response, and adverse effects. The selection of embolic agents is critical to TACE success, with ongoing research focusing on modifying their structure, size, homogeneity, biocompatibility, and biodegradability for improved outcomes.
Transarterial chemoembolization (TACE) is a recommended treatment for patients suffering from intermediate and advanced hepatocellular carcinoma (HCC). As compared to the conventional TACE, drug-eluting bead TACE demonstrates several advantages in terms of survival, treatment response, and adverse effects. The selection of embolic agents is critical to the success of TACE. Many studies have been performed on the modification of the structure, size, homogeneity, biocompatibility, and biodegradability of embolic agents. Continuing efforts are focused on efficient loading of versatile chemotherapeutics, controlled sizes for sufficient occlusion, real-time detection intra- and post-procedure, and multimodality imaging-guided precise treatment. Here, we summarize recent advances and applications of microspheres and nanoparticles in TACE for HCC. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available